Acting Editor-in-Chief
Shanker Gupta, Ph.D.
Dr. Shanker Gupta has stepped up to take on the role of Acting Editor-in-Chief while PDA conducts the search for a permanent Editor. Richard V. Levy, PhD, retired as Editor-in-Chief of the PDA Journal of Pharmaceutical Science and Technology (JPST) after almost four years as its head. Gupta has been a member of the Journal Editorial Board since 2019 and, most recently, has served as an Associate Editor, helping evaluating and managing JPST submissions. He has been a PDA member for more than 30 years.
Gupta has worked with the National Institutes of Health for almost 20 years, currently as a senior scientist in the Division of Cancer Prevention of the National Cancer Institute and consulting with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases. At NIH, he has been responsible for managing multiple translational projects designed to generate clinical product for use in Phase I and Phase 2 clinical trials. Gupta also collaborates with contract teams and actively participates in the design and development of formulations of several promising agents that have resulted in patent filings. He has supported over 40 IND submissions.
Gupta holds a BS (Hons) in pharmacy from the University of Florida and a PhD in pharmaceutical chemistry from the University of Michigan, Ann Arbor. Prior to joining NIH, he was a project leader in sterile products development at Abbott Laboratories and filed the IND for the expanded use of a lung surfactant product (Survanta®), which was the first product of its kind for neonatal respiratory distress syndrome. Gupta has published more than 20 papers in various peer-reviewed journals and contributed to books.
Associate Editors
Tony Cundell, PhD, Microbiological Consulting, LLC
Editorial Board
| James Akers, PhD, Consultant |  Jose Caraballo, MBA/ME, Kite, a Gilead Company |
 Dayue Chen, PhD, Genentech |
H. Gregg Claycamp, PhD, Independent Consultant |
 Tony Cundell, PhD, Microbiological Consulting, LLC |
 Fenton Fong, Msc, xCellarate Technology Consulting Inc. |
| Shanker Gupta, PhD, U.S. National Institutes of Health |
 Ankur Kulshrestha, PhD, Bristol Myers Squibb |
 Kelvin Lee, PhD, NIIMBL |
Richard V. Levy, PhD, PDA (ret.)  |
 Duncan Low, PhD, Claymore Biopharm LLC |
H anns-Christian Mahler, PhD, ten23 health AG |
|
Wendy R. Saffell-Clemmer, MS, Baxter International Inc.
|
Neha Pardeshi, PhD, Amgen
|
 Alicja Sobantka , PhD, Octapharma |
 Tim Sandle, PhD, Bio Products Laboratory Limited |
 Edward C. Tidswell, PhD, Merck |
 István Szikora, MBA/MS, Novartis |
 Kelly Waldron, PhD, ValSource |
 Henrietta Vinnerås, MSc, Fresenius Kabi AB |
| Glenn Wright, PDA |  Wesley Workman, PhD, Workman Biotech Consultants LLC |
 Steve Zdravkovic, BS, Baxter International Inc. |
 Earl Zablackis, PhD, Sanofi Pasteur |
|
Daniele Zuccato, MS, SCHOTT AG
|
 Qingyu Zeng, PhD, West Pharmaceutical Services |
PDA, Inc., Leadership
Chair
Susan Schniepp, Regulatory Compliance Associates Inc.
Chair-elect
Anil Sawant, PhD, Merck & Co., Inc./Merck Sharp & Dohme
Treasurer
Melissa Seymour, Biogen, Inc.
Secretary
Emma Ramnarine, Roche Pharma
Immediate Past Chair
Jette Christensen, PhD, Novo Nordisk
Directors
Barbara Allen, PhD, Eli Lilly & Company
Bettine Boltres, West PharmaceuticalServices
Tia Bush, Amgen, Inc.
Javier Camposano, Celltrion
Mirko Gabriele, Thermo Fisher Scientific
Ghada Haddad, PhD, Merck & Co., Inc./Merck Sharp & Dohme
Andrew Hopkins, Abbvie
Stephan Krause, PhD, AstraZeneca Biologics
Amy McDaniel, Bristol Myers Squibb
Mary Oates, PhD, Sanofi Pasteur
Mathias Romacker, (ret.)
Osamu Shirokizawa, Lifescienta
PDA Staff Liaisons
Richard Johnson, President & CEO
Walter Morris, Sr. Director, Publishing & Press Relations